Medical and Pharmaceutical GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most The first patient has been screened with the R&D-stage test in a Phase III study Rowan DunneNovember 19, 2024
Medical and Pharmaceutical Korean consortium propels lung cancer drug development with AI, supercomputers It is being led by Seoul's bioscience company J INTS BIO Rowan DunneNovember 18, 2024
Medical and Pharmaceutical Oklahoma uses injectable ‘glowing’ agent to light up lung cancer cells in surgery Cytalux was invented by a researcher from Purdue University in Indiana Rowan DunneNovember 15, 2024
AI and Autonomy Qure.ai’s qXR software helps provide Scottish woman with lung cancer diagnosis A timely follow up low-dose CT scan confirmed that she had the disease Rowan DunneNovember 14, 2024
Medical and Pharmaceutical Chinese researchers develop breath analysis tech for lung cancer detection It works by identifying abnormal levels of isoprene -- a volatile organic compound Rowan DunneNovember 6, 2024
Medical and Pharmaceutical Largest U.S. municipal healthcare system does over 10K lung cancer screenings since 2022 The achievement was announced as Lung Cancer Awareness Month begins Rowan DunneNovember 4, 2024
Health & Wellness Breath Diagnostics onboards new president and closes critical financing Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices Joseph MortonOctober 31, 2024
Health & Wellness Cancer survivor preps to take on 7 marathons with just 1 lung The "Great World Race" through all 7 continents is sponsored by the LUNGevity Foundation non-profit Rowan DunneOctober 31, 2024
Medical and Pharmaceutical Ireland launches largest lung cancer research program to date This €4.9-million-euro initiative is being funded by the Irish Cancer Society Rowan DunneOctober 30, 2024
Medical and Pharmaceutical South Korea’s Yuhan has 690% profit spike on U.S. lung cancer drug sales Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August Rowan DunneOctober 28, 2024